Relocation of minimal luminal diameter after bare metal and drug-eluting stent implantation: Incidence and impact on angiographic late loss

Catheterization and Cardiovascular Interventions

Volumn 69, Issue 2, 2007, Pages 181-188

  Costa, Marco A ^a   Sabaté, Manel ^b   Angiolillo, Dominick J ^a   Hu, Paula ^a   Jimenez Quevedo, Pilar ^b   Corros, Cecilia ^b   Alfonso, Fernando ^b   Hernandez Antolin, Rosana ^b   Macaya, Carlos ^b   Bass, Theodore A ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Angiography; Coronary disease; Drug eluting stents; Restenosis

Indexed keywords

ACETYLSALICYLIC ACID; GLYCERYL TRINITRATE; METAL; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CALCULATION; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; EVALUATION; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LOADING DRUG DOSE; MALE; MINIMAL LUMEN DIAMETER; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PROSTHESIS FAILURE; RESTENOSIS;

AGED; ANALYSIS OF VARIANCE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DIABETES COMPLICATIONS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; ROC CURVE; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 33846850365     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.20972     Document Type: Article

References (16)

1. Costa MA, Simon DI. Molecular basis of restenosis and drug-eluting stents. Circulation 2005;111:2257-2273.
2. Sousa JE, Costa MA, Tuzcu EM, Yadav JS, Ellis S. New frontiers in interventional cardiology. Circulation 2005;111:671-681.
3. Strauss BH, Serruys PW, de heerder IK, Tijssen JG, Bertrand ME, Puel J, Meier B, Kaufmann U, Stauffer JC, Rickards AF, et al. Relative risk analysis of angiographic predictors of restenosis within the coronary Wallstent. Circulation 1991;84:1636-1643.
4. Kuntz RE, Gibson CM, Nobuyoshi M, Baim DS. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol 1993;21:15-25.
5. Mehilli J, Kastrati A, Wessely R, Dibra A, Hausleiter J, Jaschke B, Dirschinger J, Schomig A. Randomized trial of a nonpolymerbased rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss. Circulation 2006;113:273-279.
6. Morice MC, Serrays PW, Sousa JE, Fajadet J, Ban ayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780.
7. Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation 2005;111:3435-3442.
8. Mauri L, Orav EJ, O'Malley AJ, Moses JW, Leon MB, Holmes DR Jr, Teirstein PS, Schofer J, Breithardt G, Cutlip DE, Kereiakes DJ, Shi C, Firth BG, Donohoe DJ, Kuntz RE. Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents. Circulation 2005;111:321-327.
9. Ellis SG, Popma JJ, Lasala JM, Koglin JJ, Cox DA, Hermiller J, O'shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Stone GW. Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: Analysis from the TAXUS-IV trial. J Am Coll Cardiol 2005;45:1193-1200.
10. Agostoni P. Letter regarding article by Mauri et al, "Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison". Circulation 2005;112:e358.
11. Sabate M, Costa MA, Kozuma K, Kay IP, van der Wiel CJ, Verin V, Wijns W, Serruys PW, Dose Finding Study Group. Methodological and clinical implications of the relocation of the minimal luminal diameter after intracoronary radiation therapy. J Am Coll Cardiol 2000;36:1536-1541.
12. Sabate M, Jimenez-Quevedo P, Angiolillo DJ, Gomez-Hospital JA, Alfonso F, Hernandez-Antolin R, Goicolea J, Banuelos C, Escaned J, Moreno R, Fernandez C, Fernandez-Aviles F, Macaya C. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: The diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 2005;12:2175-2183.
13. Abizaid A, Albertal M, Costa MA, Abizaid AS, Staico R, Feres F, Mattos LA, Sousa AG, Moses J, Kipshidize N, Roubin GS, Mehran R, New G, Leon MB, Sousa JE. First human experience with the 17-β-estradiol-eluting stent: The estrogen and stents to eliminate restenosis (EASTER) trial. J Am Coll Cardiol 2004;43:1118-1121.
14. Costa MA, Sabate M, Kay IP, de Feyter PJ, Kozuma K, Serrano P, de Valk V, Albertal M, Ligthart JM, Disco C, Foley DP, Serruys PW. Three-dimensional intravascular ultrasonic volumetric quantification of stent recoil and neointimal formation of two new generation tubular stents. Am J Cardiol 2000;85:135-139.
15. Costa MA, Kozuma K, Gaster AL, van Der Giessen WJ, Sabate M, Foley DP, Kay IP, Ligthart JM, Thayssen P, van Den Brand MJ, de Feyter PJ, Serruys PW. Three dimensional intravascular ultrasonic assessment of the local mechanism of restenosis after balloon angioplasty. Heart 2001;85:73-79.
16. Tsuchida K, Garcia-Garcia HM, Ong AT, Valgimigli M, Aoki J, Rademaker TA, Morel MA, vanEsG , Bruining N, Serruys PW. Revisiting late loss and neointimal volumetric measurements in a drug-eluting stent trial: Analysis from the SPIRIT FIRST trial. Catheter Cardiovasc Interv 2006;67:188-197.